title: [Duchenne Boulogne myopathy and free radicals; potential value of lazaroids in the treatment of this disease].
authors: Département d'Immunologie, Immunopharmacologie et Pathologie, Université Louis Pasteur, Illkirch.
authors: P
authors: P
authors: Poindron
authors: L
authors: L
authors: Metzinger
authors: J M
authors: JM
authors: Warter
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D002460:Cell Line; D004195:Disease Models, Animal; D016189:Dystrophin / Q000378:metabolism; D005609:Free Radicals / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000166:cytology / Q000187:drug effects / Q000196:embryology; D009136:Muscular Dystrophies / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D009137:Muscular Dystrophy, Animal / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D011281:Pregnatrienes / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D016189:Dystrophin; D005609:Free Radicals; D011281:Pregnatrienes
vernacular_title: Myopathie de Duchenne de Boulogne et radicaux libres; intérêt potentiel des lazaroïdes dans le traitement de cette maladie.